Artificial Intelligence in Health: New Opportunities, Challenges, and Practical Implications.


Journal

Yearbook of medical informatics
ISSN: 2364-0502
Titre abrégé: Yearb Med Inform
Pays: Germany
ID NLM: 9312666

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 18 12 2019
Statut: ppublish

Résumé

To summarise the state of the art during the year 2018 in consumer health informatics and education, with a special emphasis on the special topic of the International Medical Informatics Association (IMIA) Yearbook for 2019: "Artificial intelligence in health: new opportunities, challenges, and practical implications". We conducted a systematic search of articles published in PubMed using a predefined set of queries that identified 99 potential articles for review. These articles were screened according to topic relevance and 14 were selected for consideration as best paper candidates. The 14 papers were then presented to a panel of international experts for full paper review and scoring. Three papers that received the highest score were discussed in a consensus meeting and were agreed upon as best papers on artificial intelligence in health for patients and consumers in the year 2018. Only a small number of 2018 papers reported Artificial Intelligence (AI) research for patients and consumers. No studies were found on AI applications designed specifically for patients or consumers, nor were there studies that elicited patient and consumer input on AI. Currently, the most common use of AI for patients and consumers lies in secondary analysis of social media data (e.g., online discussion forums). In particular, the three best papers shared a common methodology of using data-driven algorithms (such as text mining, topic modelling, Latent Dirichlet allocation modelling), combined with insight-led approaches (e.g., visualisation, qualitative analysis and manual review), to uncover patient and consumer experiences of health and illness in online communities. While discussion remains active on how AI could 'revolutionise' healthcare delivery, there is a lack of direction and evidence on how AI could actually benefit patients and consumers. Perhaps instead of primarily focusing on data and algorithms, researchers should engage with patients and consumers early in the AI research agenda to ensure we are indeed asking the right questions, and that important use cases and critical contexts are identified together with patients and consumers. Without a clear understanding on why patients and consumers need AI in the first place, or how AI could support individuals with their healthcare needs, it is difficult to imagine the kinds of AI applications that would have meaningful and sustainable impact on individual daily lives.

Identifiants

pubmed: 31419829
doi: 10.1055/s-0039-1677935
pmc: PMC6697520
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

174-178

Informations de copyright

Georg Thieme Verlag KG Stuttgart.

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

J Biomed Inform. 2013 Dec;46(6):998-1005
pubmed: 24025513
P T. 2014 Jul;39(7):491-520
pubmed: 25083128
J Med Internet Res. 2015 Jun 05;17(6):e138
pubmed: 26048075
Ann N Y Acad Sci. 2017 Jan;1387(1):44-53
pubmed: 27750378
Comput Human Behav. 2018 Jan;78:98-112
pubmed: 29456286
J Med Internet Res. 2018 Mar 14;20(3):e85
pubmed: 29540337
J Am Med Inform Assoc. 2018 Sep 1;25(9):1248-1258
pubmed: 30010941
Nature. 2018 Nov;563(7733):S141-S143
pubmed: 30487629
JMIR Med Inform. 2018 Nov 29;6(4):e45
pubmed: 30497991
Yearb Med Inform. 2019 Aug;28(1):165-173
pubmed: 31022749
NPJ Digit Med. 2018 Oct 2;1:53
pubmed: 31304332

Auteurs

Annie Y S Lau (AYS)

Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, Australia.

Pascal Staccini (P)

IRIS Department, URE RETINES, Faculté de Médecine, Université Côte d'Azur, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH